Merit Medical Systems Inc (MMSI) stock
Close on Nov 12, 2026Market cap $5.19BP/E 32.6Yield –
Merit Medical Systems Inc grew revenue 9.1% to $1.61B over the twelve months to Sep 30, 2026. Operating income rose 30.2% to $217.52M, moving the operating margin from 11.3% to 13.5%. Free cash flow was $203.59M, down 1.6% from a year earlier. At the latest close the market valued the company at $5.19B, 32.6 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.19B
- P/E ratio
- 32.6
- Price to sales
- 3.22
- Price to book
- 2.98
- Dividend yield
- –
- Free cash flow yield
- 3.92%
Fundamentals
- Revenue
- $1.61B
- Net income
- $160.12M
- EPS, diluted
- $2.66
- Free cash flow
- $203.59M
- Book value per share
- $28.89
- Diluted shares
- 60M
Trading
- Next earnings
- Feb 23, 2027 (estimated, during market hours)
- Previous close
- $88.07
- Open
- $88.28
- Day's range
- $85.57 – $89.53
- Volume
- 540,030
- Average volume (20 days)
- 773,623
- Index membership
- S&P SmallCap 600, Russell 2000, Russell 3000
- Beta (5 years)
- 0.69
- 52-week range
- $59.74 – $94.85
- RSI (14 days)
- 45.2
- Volatility (1 year)
- 31.1%
- Relative volume
- 0.69×
- WACC
- 7.7%
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | MMSI | S&P 500 | Difference | MMSI per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.4% | -2.7% | −0.7 pts | ||
| 3 months | -4.9% | -1.7% | −3.2 pts | ||
| Year to date | -1.6% | +11.9% | −13.5 pts | ||
| 1 year | -1.6% | +12.0% | −13.6 pts | ||
| 3 years | +24.5% | +78.2% | −53.7 pts | +7.6% | +21.2% |
| 5 years | +27.8% | +73.2% | −45.4 pts | +5.0% | +11.6% |
| 10 years | +276.9% | +309.6% | −32.7 pts | +14.2% | +15.1% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Merit Medical Systems filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Results
- Results
About Merit Medical Systems
Surgical & Medical Instruments & Apparatus
Merit Medical Systems, Inc. designs, develops, and manufactures medical devices used in interventional, diagnostic, and therapeutic procedures. The company operates through two primary segments: cardiovascular and endoscopy. Its cardiovascular offerings include catheters, guide wires, introducer sheaths, embolotherapy products, biopsy systems, fluid management tools, and spine intervention devices, along with contract manufacturing services for original equipment manufacturers. Its endoscopy segment provides pulmonary and gastrointestinal devices such as esophageal stents and dilation balloons. The company sells its products to hospitals, acute care facilities, and healthcare professionals, including physicians, technicians, and nurses.
Company profile, executives and historyMerit Medical Systems stock: common questions
What is Merit Medical Systems's stock price?
MMSI closed at $86.69 on Nov 12, 2026, down 1.57% on the day. Over the past 52 weeks it traded between $59.74 and $94.85.
What is Merit Medical Systems's market cap?
Merit Medical Systems was worth $5.19B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is MMSI's P/E ratio?
MMSI trades at 32.6 times earnings, based on diluted earnings per share of $2.66 over the twelve months to Sep 30, 2026.
How much revenue does Merit Medical Systems make?
Merit Medical Systems reported revenue of $1.61B for the twelve months to Sep 30, 2026, up 9.1% from a year earlier.
Does Merit Medical Systems pay a dividend?
No. Merit Medical Systems has not paid a cash dividend over the last twelve months.
When does Merit Medical Systems report earnings next?
Merit Medical Systems is expected to report Q4 FY2026 results on Feb 23, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.
How has MMSI stock performed over the past year?
Including dividends, MMSI returned -1.6% over the past year, against +12.0% for the S&P 500.
How many MMSI shares are sold short?
4M shares were sold short at the latest FINRA report, 6.85% of the float, or 5.1 days of average trading volume.
Who are Merit Medical Systems's competitors?
Companies most similar to Merit Medical Systems by business, industry and size include IART, PEN, TFX, ICUI, STVN.
See a number that looks wrong?